QuickView for L-aspartate transmembrane transporter activity (biogroup)

1. L1000 CMAP - Prostate cancer PC3.101 cells with CRISPR-targeted gene knockouts
2. Neural progenitor cells treated with active and inactive forms of BET bromodomain inhibitor JQ1
3. Lung of COPD patients; regional variation in expression profiles
4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
5. L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations

There were no matches for L-aspartate transmembrane transporter activity

1. Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 …
2. Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against …
3. Glycerol Phenylbutyrate Corrector Therapy For CF (Cystic Fibrosis)
4. A Repeat Dose Study to Investigate the Interaction of GSK2190915 on the Pharmacokinetics of Rosuvast…
5. Study of Ivacaftor in Cystic Fibrosis Subjects Aged 6 to 11 Years With the G551D Mutation